A citation-based method for searching scientific literature


List of co-cited articles
315 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Skeletal muscle laminin and MDC1A: pathogenesis and treatment strategies.
Kinga I Gawlik, Madeleine Durbeej. Skelet Muscle 2011
72
30

Omigapil ameliorates the pathology of muscle dystrophy caused by laminin-alpha2 deficiency.
Michael Erb, Sarina Meinen, Patrizia Barzaghi, Lazar T Sumanovski, Isabelle Courdier-Früh, Markus A Rüegg, Thomas Meier. J Pharmacol Exp Ther 2009
63
27


Autophagy is increased in laminin α2 chain-deficient muscle and its inhibition improves muscle morphology in a mouse model of MDC1A.
Virginie Carmignac, Martina Svensson, Zandra Körner, Linda Elowsson, Cintia Matsumura, Kinga I Gawlik, Valerie Allamand, Madeleine Durbeej. Hum Mol Genet 2011
90
22

Losartan, a therapeutic candidate in congenital muscular dystrophy: studies in the dy(2J) /dy(2J) mouse.
Moran Elbaz, Nurit Yanay, Shlomit Aga-Mizrachi, Zivia Brunschwig, Ibaa Kassis, Keren Ettinger, Vivian Barak, Yoram Nevo. Ann Neurol 2012
54
22



Diagnostic approach to the congenital muscular dystrophies.
Carsten G Bönnemann, Ching H Wang, Susana Quijano-Roy, Nicolas Deconinck, Enrico Bertini, Ana Ferreiro, Francesco Muntoni, Caroline Sewry, Christophe Béroud, Katherine D Mathews,[...]. Neuromuscul Disord 2014
177
20


Bortezomib partially improves laminin α2 chain-deficient muscular dystrophy.
Zandra Körner, Cibely C Fontes-Oliveira, Johan Holmberg, Virginie Carmignac, Madeleine Durbeej. Am J Pathol 2014
22
36

Laminin alpha2 chain-null mutant mice by targeted disruption of the Lama2 gene: a new model of merosin (laminin 2)-deficient congenital muscular dystrophy.
Y Miyagoe, K Hanaoka, I Nonaka, M Hayasaka, Y Nabeshima, K Arahata, Y Nabeshima, S Takeda. FEBS Lett 1997
203
20

Quantitative proteomic analysis reveals metabolic alterations, calcium dysregulation, and increased expression of extracellular matrix proteins in laminin α2 chain-deficient muscle.
Bruno Menezes de Oliveira, Cintia Y Matsumura, Cibely C Fontes-Oliveira, Kinga I Gawlik, Helena Acosta, Patrik Wernhoff, Madeleine Durbeej. Mol Cell Proteomics 2014
25
32

Genotype-phenotype correlation in a large population of muscular dystrophy patients with LAMA2 mutations.
Fatemeh Geranmayeh, Emma Clement, Lucy H Feng, Caroline Sewry, Judith Pagan, Rachael Mein, Stephen Abbs, Louise Brueton, Anne-Marie Childs, Heinz Jungbluth,[...]. Neuromuscul Disord 2010
100
20

Genotype/phenotype analysis in Chinese laminin-α2 deficient congenital muscular dystrophy patients.
H Xiong, D Tan, S Wang, S Song, H Yang, K Gao, A Liu, H Jiao, B Mao, J Ding,[...]. Clin Genet 2015
33
24

Laminin-deficient muscular dystrophy: Molecular pathogenesis and structural repair strategies.
Peter D Yurchenco, Karen K McKee, Judith R Reinhard, Markus A Rüegg. Matrix Biol 2018
44
20

Linker proteins restore basement membrane and correct LAMA2-related muscular dystrophy in mice.
Judith R Reinhard, Shuo Lin, Karen K McKee, Sarina Meinen, Stephanie C Crosson, Maurizio Sury, Samantha Hobbs, Geraldine Maier, Peter D Yurchenco, Markus A Rüegg. Sci Transl Med 2017
43
20

Laminin-211 in skeletal muscle function.
Johan Holmberg, Madeleine Durbeej. Cell Adh Migr 2013
73
20

LAMA2 gene mutation update: Toward a more comprehensive picture of the laminin-α2 variome and its related phenotypes.
Jorge Oliveira, Angela Gruber, Márcio Cardoso, Ricardo Taipa, Isabel Fineza, Ana Gonçalves, Andreas Laner, Thomas L Winder, Jocelyn Schroeder, Julie Rath,[...]. Hum Mutat 2018
31
25

Apoptosis inhibitors and mini-agrin have additive benefits in congenital muscular dystrophy mice.
Sarina Meinen, Shuo Lin, Raphael Thurnherr, Michael Erb, Thomas Meier, Markus A Rüegg. EMBO Mol Med 2011
35
20

Life or death by NFκB, Losartan promotes survival in dy2J/dy2J mouse of MDC1A.
M Elbaz, N Yanay, S Laban, M Rabie, S Mitrani-Rosenbaum, Y Nevo. Cell Death Dis 2015
16
43

The extracellular matrix protein laminin α2 regulates the maturation and function of the blood-brain barrier.
Michael J Menezes, Freyja K McClenahan, Cindy V Leiton, Azeez Aranmolate, Xiwei Shan, Holly Colognato. J Neurosci 2014
107
17

Laminin alpha1 chain reduces muscular dystrophy in laminin alpha2 chain deficient mice.
Kinga Gawlik, Yuko Miyagoe-Suzuki, Peter Ekblom, Shin'ichi Takeda, Madeleine Durbeej. Hum Mol Genet 2004
101
17

Form and function: the laminin family of heterotrimers.
H Colognato, P D Yurchenco. Dev Dyn 2000
888
17

Chimeric protein repair of laminin polymerization ameliorates muscular dystrophy phenotype.
Karen K McKee, Stephanie C Crosson, Sarina Meinen, Judith R Reinhard, Markus A Rüegg, Peter D Yurchenco. J Clin Invest 2017
32
21

Mutations in the laminin alpha 2-chain gene (LAMA2) cause merosin-deficient congenital muscular dystrophy.
A Helbling-Leclerc, X Zhang, H Topaloglu, C Cruaud, F Tesson, J Weissenbach, F M Tomé, K Schwartz, M Fardeau, K Tryggvason. Nat Genet 1995
512
17

Omigapil treatment decreases fibrosis and improves respiratory rate in dy(2J) mouse model of congenital muscular dystrophy.
Qing Yu, Arpana Sali, Jack Van der Meulen, Brittany K Creeden, Heather Gordish-Dressman, Anne Rutkowski, Sree Rayavarapu, Kitipong Uaesoontrachoon, Tony Huynh, Kanneboyina Nagaraju,[...]. PLoS One 2013
28
25

Merosin-deficient congenital muscular dystrophy. Partial genetic correction in two mouse models.
W Kuang, H Xu, P H Vachon, L Liu, F Loechel, U M Wewer, E Engvall. J Clin Invest 1998
152
15

Laminin-111 protein therapy reduces muscle pathology and improves viability of a mouse model of merosin-deficient congenital muscular dystrophy.
Jachinta E Rooney, Jolie R Knapp, Bradley L Hodges, Ryan D Wuebbles, Dean J Burkin. Am J Pathol 2012
68
15

Pathology is alleviated by doxycycline in a laminin-alpha2-null model of congenital muscular dystrophy.
Mahasweta Girgenrath, Mary Lou Beermann, Vivek K Vishnudas, Sachiko Homma, Jeffrey Boone Miller. Ann Neurol 2009
62
15

Inhibition of apoptosis improves outcome in a model of congenital muscular dystrophy.
Mahasweta Girgenrath, Janice A Dominov, Christine A Kostek, Jeffrey Boone Miller. J Clin Invest 2004
96
15

An agrin minigene rescues dystrophic symptoms in a mouse model for congenital muscular dystrophy.
J Moll, P Barzaghi, S Lin, G Bezakova, H Lochmüller, E Engvall, U Müller, M A Ruegg. Nature 2001
176
15


Bioenergetic Impairment in Congenital Muscular Dystrophy Type 1A and Leigh Syndrome Muscle Cells.
Cibely C Fontes-Oliveira, Maarten Steinz, Peter Schneiderat, Hindrik Mulder, Madeleine Durbeej. Sci Rep 2017
17
35

IGF-1/GH axis enhances losartan treatment in Lama2-related muscular dystrophy.
Anthony Accorsi, Ajay Kumar, Younghwa Rhee, Alex Miller, Mahasweta Girgenrath. Hum Mol Genet 2016
18
33

Fibrosis inhibition and muscle histopathology improvement in laminin-alpha2-deficient mice.
Yoram Nevo, Orna Halevy, Olga Genin, Itai Moshe, Tidhar Turgeman, Michal Harel, Edva Biton, Shimon Reif, Mark Pines. Muscle Nerve 2010
33
15

Proteasome inhibition improves the muscle of laminin α2 chain-deficient mice.
Virginie Carmignac, Ronan Quéré, Madeleine Durbeej. Hum Mol Genet 2011
47
12

Laminin-111 improves muscle repair in a mouse model of merosin-deficient congenital muscular dystrophy.
Pam M Van Ry, Priscilla Minogue, Bradley L Hodges, Dean J Burkin. Hum Mol Genet 2014
45
12

Linker molecules between laminins and dystroglycan ameliorate laminin-alpha2-deficient muscular dystrophy at all disease stages.
Sarina Meinen, Patrizia Barzaghi, Shuo Lin, Hanns Lochmüller, Markus A Ruegg. J Cell Biol 2007
58
12

The expanding phenotype of laminin alpha2 chain (merosin) abnormalities: case series and review.
K J Jones, G Morgan, H Johnston, V Tobias, R A Ouvrier, I Wilkinson, K N North. J Med Genet 2001
104
12

Correction of a splicing defect in a mouse model of congenital muscular dystrophy type 1A using a homology-directed-repair-independent mechanism.
Dwi U Kemaladewi, Eleonora Maino, Elzbieta Hyatt, Huayun Hou, Maylynn Ding, Kara M Place, Xinyi Zhu, Prabhpreet Bassi, Zahra Baghestani, Amit G Deshwar,[...]. Nat Med 2017
42
12

Prevalence of congenital muscular dystrophy in Italy: a population study.
Alessandra Graziano, Flaviana Bianco, Adele D'Amico, Isabella Moroni, Sonia Messina, Claudio Bruno, Elena Pegoraro, Marina Mora, Guja Astrea, Francesca Magri,[...]. Neurology 2015
41
12

In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy.
Christopher E Nelson, Chady H Hakim, David G Ousterout, Pratiksha I Thakore, Eirik A Moreb, Ruth M Castellanos Rivera, Sarina Madhavan, Xiufang Pan, F Ann Ran, Winston X Yan,[...]. Science 2016
648
10


In vivo gene editing in dystrophic mouse muscle and muscle stem cells.
Mohammadsharif Tabebordbar, Kexian Zhu, Jason K W Cheng, Wei Leong Chew, Jeffrey J Widrick, Winston X Yan, Claire Maesner, Elizabeth Y Wu, Ru Xiao, F Ann Ran,[...]. Science 2016
604
10


Laminin {alpha}1 chain corrects male infertility caused by absence of laminin {alpha}2 chain.
Mattias Häger, Kinga Gawlik, Alexander Nyström, Takako Sasaki, Madeleine Durbeej. Am J Pathol 2005
57
10


The laminin family.
Monique Aumailley. Cell Adh Migr 2013
159
10

Triggering regeneration and tackling apoptosis: a combinatorial approach to treating congenital muscular dystrophy type 1 A.
Jenny Yamauchi, Ajay Kumar, Lina Duarte, Thomas Mehuron, Mahasweta Girgenrath. Hum Mol Genet 2013
17
23

A simplified laminin nomenclature.
Monique Aumailley, Leena Bruckner-Tuderman, William G Carter, Rainer Deutzmann, David Edgar, Peter Ekblom, Jürgen Engel, Eva Engvall, Erhard Hohenester, Jonathan C R Jones,[...]. Matrix Biol 2005
567
10


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.